Elitsa Y. Dimova

2.0k total citations
55 papers, 1.6k citations indexed

About

Elitsa Y. Dimova is a scholar working on Molecular Biology, Cancer Research and Physiology. According to data from OpenAlex, Elitsa Y. Dimova has authored 55 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 30 papers in Cancer Research and 14 papers in Physiology. Recurrent topics in Elitsa Y. Dimova's work include Cancer, Hypoxia, and Metabolism (26 papers), Adipose Tissue and Metabolism (12 papers) and Mitochondrial Function and Pathology (9 papers). Elitsa Y. Dimova is often cited by papers focused on Cancer, Hypoxia, and Metabolism (26 papers), Adipose Tissue and Metabolism (12 papers) and Mitochondrial Function and Pathology (9 papers). Elitsa Y. Dimova collaborates with scholars based in Finland, Germany and United States. Elitsa Y. Dimova's co-authors include Thomas Kietzmann, Daniela Mennerich, Agnes Görlach, Andreas Petry, Carlos M. Palmeira, Pablo Hernansanz‐Agustín, Antonio Martínez‐Ruiz, Anabela P. Rolo, Peppi Koivunen and Raisa Serpi and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Elitsa Y. Dimova

53 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elitsa Y. Dimova Finland 24 737 516 284 195 154 55 1.6k
Rosella Scrima Italy 25 955 1.3× 298 0.6× 248 0.9× 271 1.4× 140 0.9× 49 1.9k
Panagiotis Liakos Greece 21 562 0.8× 483 0.9× 221 0.8× 105 0.5× 137 0.9× 58 1.3k
John J. LaPres United States 22 721 1.0× 452 0.9× 192 0.7× 94 0.5× 115 0.7× 46 1.4k
Xueyuan Bai China 27 846 1.1× 335 0.6× 327 1.2× 283 1.5× 164 1.1× 77 1.9k
Carmela Guido Italy 24 853 1.2× 444 0.9× 153 0.5× 237 1.2× 165 1.1× 35 2.0k
Xiang Lv China 22 1.2k 1.6× 328 0.6× 165 0.6× 152 0.8× 109 0.7× 83 1.8k
Hanmei Xu China 19 889 1.2× 479 0.9× 161 0.6× 160 0.8× 61 0.4× 40 1.4k
Karl Johan Tronstad Norway 28 1.1k 1.5× 366 0.7× 342 1.2× 227 1.2× 60 0.4× 61 1.9k
Rebeca Busto Spain 24 881 1.2× 483 0.9× 131 0.5× 180 0.9× 143 0.9× 59 1.7k
Hongmei Ren China 24 1.3k 1.7× 270 0.5× 211 0.7× 121 0.6× 96 0.6× 73 1.9k

Countries citing papers authored by Elitsa Y. Dimova

Since Specialization
Citations

This map shows the geographic impact of Elitsa Y. Dimova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elitsa Y. Dimova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elitsa Y. Dimova more than expected).

Fields of papers citing papers by Elitsa Y. Dimova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elitsa Y. Dimova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elitsa Y. Dimova. The network helps show where Elitsa Y. Dimova may publish in the future.

Co-authorship network of co-authors of Elitsa Y. Dimova

This figure shows the co-authorship network connecting the top 25 collaborators of Elitsa Y. Dimova. A scholar is included among the top collaborators of Elitsa Y. Dimova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elitsa Y. Dimova. Elitsa Y. Dimova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leinonen, Henri, Antti M. Salo, Ghulam Shere Raza, et al.. (2024). Metabolic characteristics of transmembrane prolyl 4-hydroxylase (P4H-TM) deficient mice. Pflügers Archiv - European Journal of Physiology. 476(9). 1339–1351. 2 indexed citations
2.
Dimova, Elitsa Y., et al.. (2022). Hypoxia ameliorates maternal diet‐induced insulin resistance during pregnancy while having a detrimental effect on the placenta. Physiological Reports. 10(9). e15302–e15302. 1 indexed citations
3.
Dimova, Elitsa Y., Joni M. Mäki, Anu Laitala, et al.. (2022). Contribution of HIF-P4H isoenzyme inhibition to metabolism indicates major beneficial effects being conveyed by HIF-P4H-2 antagonism. Journal of Biological Chemistry. 298(8). 102222–102222. 4 indexed citations
4.
Mäkelä, Kari A., Karl‐Heinz Herzig, Franziska Dengler, et al.. (2020). HIF-P4H-2 inhibition enhances intestinal fructose metabolism and induces thermogenesis protecting against NAFLD. Journal of Molecular Medicine. 98(5). 719–731. 17 indexed citations
5.
Mennerich, Daniela, Anatoly Samoylenko, Elitsa Y. Dimova, et al.. (2019). The Pro-Oncogenic Adaptor CIN85 Acts as an Inhibitory Binding Partner of Hypoxia-Inducible Factor Prolyl Hydroxylase 2. Cancer Research. 79(16). 4042–4056. 9 indexed citations
6.
Dimova, Elitsa Y., Kateryna Kubaichuk, Daniela Mennerich, et al.. (2019). The Circadian Clock Protein CRY1 Is a Negative Regulator of HIF-1α. iScience. 13. 284–304. 51 indexed citations
7.
Kietzmann, Thomas, Gail Walkinshaw, Daniela Mennerich, et al.. (2019). Systemic inactivation of hypoxia-inducible factor prolyl 4-hydroxylase 2 in mice protects from alcohol-induced fatty liver disease. Redox Biology. 22. 101145–101145. 22 indexed citations
8.
Richter, Kati, Daniela Mennerich, Kateryna Kubaichuk, et al.. (2018). USP28 Deficiency Promotes Breast and Liver Carcinogenesis as well as Tumor Angiogenesis in a HIF-independent Manner. Molecular Cancer Research. 16(6). 1000–1012. 25 indexed citations
9.
Dimova, Elitsa Y., et al.. (2018). Hypoxia causes reductions in birth weight by altering maternal glucose and lipid metabolism. Scientific Reports. 8(1). 13583–13583. 23 indexed citations
10.
Dimova, Elitsa Y., Sohvi Hörkkö, Helena Gylling, et al.. (2016). Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology. 36(4). 608–617. 75 indexed citations
11.
Myllymäki, Mikko, Elitsa Y. Dimova, Valerio Izzi, et al.. (2016). Notch Downregulation and Extramedullary Erythrocytosis in Hypoxia-Inducible Factor Prolyl 4-Hydroxylase 2-Deficient Mice. Molecular and Cellular Biology. 37(2). 8 indexed citations
12.
Petry, Andreas, et al.. (2016). Differential transcriptional regulation of hypoxia-inducible factor-1α by arsenite under normoxia and hypoxia: involvement of Nrf2. Journal of Molecular Medicine. 94(10). 1153–1166. 29 indexed citations
13.
Koivunen, Peppi, Raisa Serpi, & Elitsa Y. Dimova. (2016). Hypoxia-inducible factor prolyl 4-hydroxylase inhibition in cardiometabolic diseases. Pharmacological Research. 114. 265–273. 23 indexed citations
14.
Dimova, Elitsa Y., et al.. (2015). Obesity and inflammation: reduced cytokine expression due to resveratrol in a human in vitro model of inflamed adipose tissue. Frontiers in Pharmacology. 6. 79–79. 48 indexed citations
15.
Mennerich, Daniela, Elitsa Y. Dimova, & Thomas Kietzmann. (2014). Direct phosphorylation events involved in HIF-α regulation: the role of GSK-3β. PubMed. 2. 35–35. 15 indexed citations
16.
Götz, Claudia, et al.. (2014). GSK3β-Dependent Phosphorylation Alters DNA Binding, Transactivity and Half-Life of the Transcription Factor USF2. PLoS ONE. 9(9). e107914–e107914. 7 indexed citations
17.
Kietzmann, Thomas, et al.. (2010). FOXO1 and HNF-4 are involved in regulation of hepatic glucokinase gene expression by Resveratrol. Zeitschrift für Gastroenterologie. 48(1). 1 indexed citations
18.
Kietzmann, Thomas, Elitsa Y. Dimova, Daniela Flügel, & Jens‐Gerd Scharf. (2006). Oxygen: Modulator of Physiological and Pathophysiological Processes in the Liver. Zeitschrift für Gastroenterologie. 44(1). 67–76. 40 indexed citations
19.
20.
Dimova, Elitsa Y., et al.. (1999). Autoimmune Thyroid Disorders in Juvenile Chronic Arthritis and Systemic Lupus Erythematosus. Advances in experimental medicine and biology. 455. 55–60. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosella Scrima Breakdown of academic impact, for papers by Panagiotis Liakos Breakdown of academic impact, for papers by John J. LaPres Breakdown of academic impact, for papers by Xueyuan Bai Breakdown of academic impact, for papers by Carmela Guido Breakdown of academic impact, for papers by Xiang Lv Breakdown of academic impact, for papers by Hanmei Xu Breakdown of academic impact, for papers by Karl Johan Tronstad Breakdown of academic impact, for papers by Rebeca Busto Breakdown of academic impact, for papers by Hongmei Ren
Rankless by CCL
2026